Home4503 • TYO
add
Astellas Pharma Inc
Previous close
¥1,541.00
Day range
¥1,519.00 - ¥1,549.50
Year range
¥1,426.00 - ¥2,360.50
Market cap
2.76T JPY
Avg Volume
9.08M
P/E ratio
160.71
Dividend yield
4.58%
Primary exchange
TYO
Top news
Financials
Income Statement
Revenue
Net income
(JPY) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 414.60B | 17.04% |
Operating expense | 374.47B | 56.01% |
Net income | -33.28B | 27.85% |
Net profit margin | -8.03 | 38.33% |
Earnings per share | — | — |
EBITDA | 15.55B | -79.26% |
Effective tax rate | 31.61% | — |
Balance Sheet
Total assets
Total liabilities
(JPY) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 335.69B | -15.36% |
Total assets | 3.57T | 45.31% |
Total liabilities | 1.97T | 108.06% |
Total equity | 1.60T | — |
Shares outstanding | 1.79B | — |
Price to book | 1.73 | — |
Return on assets | -2.38% | — |
Return on capital | -3.38% | — |
Cash Flow
Net change in cash
(JPY) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -33.28B | 27.85% |
Cash from operations | 71.98B | -37.73% |
Cash from investing | -22.16B | 2.47% |
Cash from financing | 30.93B | 129.60% |
Net change in cash | 81.71B | 1,742.06% |
Free cash flow | 9.41B | 126.63% |
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
14,484